Barclays
KALA icon

Barclays’s KALA BIO KALA Stock Holding History

Barclays’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9
Closed -$31K – 5152
2022
Q1 		$31K Sell
9
-20
-69% -$52.4K ﹤0.01% 4297
2021
Q4 		$88K Buy
29
+15
+107% +$69.6K ﹤0.01% 3755
2021
Q3 		$88K Buy
14
+4
+40% +$34.5K ﹤0.01% 3956
2021
Q2 		$125K Sell
10
-14
-58% -$220K ﹤0.01% 3758
2021
Q1 		$403K Buy
24
+19
+380% +$371K ﹤0.01% 3308
2020
Q4 		$88K Sell
5
-7
-58% -$132K ﹤0.01% 4184
2020
Q3 		$218K Sell
12
-52
-81% -$1.2M ﹤0.01% 3792
2020
Q2 		$1.68M Buy
64
+58
+967% +$1.64M ﹤0.01% 2288
2020
Q1 		$131K Sell
6
-3
-33% -$47.9K ﹤0.01% 4603
2019
Q4 		$83K Buy
9
+4
+80% +$38.6K ﹤0.01% 5563
2019
Q3 		$50K Sell
5
-1
-17% -$12.2K ﹤0.01% 5906
2019
Q2 		$102K Buy
6
+3
+100% +$49.7K ﹤0.01% 5680
2019
Q1 		$61K Buy
3
+2
+200% +$35.5K ﹤0.01% 5728
2018
Q4 		$10K Sell
1
-2
-67% -$34.7K ﹤0.01% 6172
2018
Q3 		$62K Sell
3
-1
-25% -$30.5K ﹤0.01% 5932
2018
Q2 		$129K Buy
4
+2
+100% +$76.7K ﹤0.01% 5070
2018
Q1 		$89K Buy
2
+1
+100% +$38K ﹤0.01% 5462
2017
Q4 		$65K Sell
1
-4
-80% -$187K ﹤0.01% 5563
2017
Q3 		$273K Buy
+5
New +$274K ﹤0.01% 4158

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Barclays's KALA Position: Q2 2022 in Review

Barclays sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 9 shares — an estimated $31K sold.

Barclays first reported a position in KALA in Q3 2017 and held it in 19 quarters. The position peaked at $1.68M in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Barclays reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 9 KALA BIO shares in Q2 2022, an estimated $31K.
  • Barclays first reported a position in KALA BIO in Q3 2017 and held it in 19 quarters.
  • Barclays's KALA BIO position peaked at $1.68M in Q2 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.